A Randomized, Controlled Trial of Cognitive-Behavioral Therapy for Augmenting Pharmacotherapy in Obsessive-Compulsive Disorder

OBJECTIVE: Although serotonin reuptake inhibitors (SRIs) are approved for the treatment of obsessive-compulsive disorder (OCD), most OCD patients who have received an adequate SRI trial continue to have clinically significant OCD symptoms. The purpose of this study was to examine the effects of augm...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Simpson, Helen Blair, Foa, Edna B., Liebowitz, Michael R., Ledley, Deborah Roth, Huppert, Jonathan D., Cahill, Shawn, Vermes, Donna, Schmidt, Andrew B., Hembree, Elizabeth, Franklin, Martin, Campeas, Raphael, Hahn, Chang-Gyu, Petkova, Eva
פורמט: Artigo
שפה:Inglês
יצא לאור: 2008
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3945728/
https://ncbi.nlm.nih.gov/pubmed/18316422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.ajp.2007.07091440
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים